Plunkett Research Online: F-Star Therapeutics Inc

F-STAR THERAPEUTICS INC (FSTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than i.....


F-STAR THERAPEUTICS INC

Ticker: FSTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 44 12-2349-7400
Fax:
Address: 35 Parkwood Dr., Babraham Research Campus
Cambridge, CB22 3AT United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than i.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture